Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AG-PRAVASTATIN 20 MG — DIN 02476150

PRAVASTATIN SODIUM : 20 MG · ANGITA PHARMA INC. · TABLET · wholesale supply in Canada

Health Canada status: MARKETED

What is AG-PRAVASTATIN?

AG-PRAVASTATIN 20 MG contains PRAVASTATIN SODIUM : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02476150, held by ANGITA PHARMA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 04-Dec-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

How much does Pravastatin cost around the world?

Pravastatin is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
United Statesacquisition486USD███.██
Australiaex-manufacturer1142AUD███.██
South Africasingle exit price1120ZAR███.██
Greeceproducer price (ex-factory)1212EUR███.██
SwedenAIP (pharmacy purchase price)24SEK███.██
United Kingdomhospital33GBP███.██
Saudi Arabiapublic22SAR███.██

169 pack listings across 45 brand entries and 7 price bases, refreshed 08 Sep 2026. Ranges span every Pravastatin pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.

Ask Nexara for a landed Canadian price

Is there a generic Pravastatin in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

34 holders have a Canadian DIN containing Pravastatin, across 126 DINs, of which 51 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
JAMP PHARMA CORPORATION66JAMP PRAVASTATIN TABLETS, JAMP-PRAVASTATINSourceable in Canada
MANTRA PHARMA INC63M-PRAVASTATINSourceable in Canada
MARCAN PHARMACEUTICALS INC63IPG-PRAVASTATIN, MAR-PRAVASTATINSourceable in Canada
TEVA CANADA LIMITED63NTP-PRAVASTATIN, TEVA-PRAVASTATINSourceable in Canada
ACCORD HEALTHCARE INC33ACH-PRAVASTATINSourceable in Canada
ANGITA PHARMA INC.33AG-PRAVASTATINSourceable in Canada
APOTEX INC33APO-PRAVASTATINSourceable in Canada
AURO PHARMA INC33AURO-PRAVASTATINSourceable in Canada
BIOMED PHARMA33BIO-PRAVASTATINSourceable in Canada
MINT PHARMACEUTICALS INC33MINT-PRAVASTATINSourceable in Canada
NORA PHARMA INC33NRA-PRAVASTATINSourceable in Canada
PHARMASCIENCE INC33PMS-PRAVASTATINSourceable in Canada

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label20 MG
Dosage formTABLET
RouteORAL

Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.

Substance and classification

Active substancePravastatin
ATC codeC10AA03
AHFS class24:06.08
Biosimilar biologicNo

Confirm the pack and get a price

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02476150
DIN (unpadded, as printed on some documents)2476150
Brand nameAG-PRAVASTATIN
Generic / active ingredientPRAVASTATIN SODIUM : 20 MG
Market authorization holderANGITA PHARMA INC.
Health Canada schedulePrescription
ATC codeC10AA03
ATC anatomical main groupC — Cardiovascular system
ATC therapeutic subgroupC10AA
Current statusMARKETED
Status date04-Dec-2019
Original market date2019-12-04 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record Approved product monograph (PDF)

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

51 of 126 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
ACH-PRAVASTATIN20 MGTABLETACCORD HEALTHCARE INCMARKETED02440652
ACH-PRAVASTATIN40 MGTABLETACCORD HEALTHCARE INCMARKETED02440660
ACH-PRAVASTATIN10 MGTABLETACCORD HEALTHCARE INCMARKETED02440644
AG-PRAVASTATIN40 MGTABLETANGITA PHARMA INC.MARKETED02476169
AG-PRAVASTATIN10 MGTABLETANGITA PHARMA INC.MARKETED02476142
APO-PRAVASTATIN40 MGTABLETAPOTEX INCMARKETED02243508
APO-PRAVASTATIN10 MGTABLETAPOTEX INCMARKETED02243506
APO-PRAVASTATIN20 MGTABLETAPOTEX INCMARKETED02243507
AURO-PRAVASTATIN40 MGTABLETAURO PHARMA INCMARKETED02458993
AURO-PRAVASTATIN10 MGTABLETAURO PHARMA INCMARKETED02458977

2 · Same class — other molecules in ATC C10AA

MoleculeCanadian brandsDINsMarketedSourceable
AtorvastatinACH-ATORVASTATIN CALCIUM · AG-ATORVASTATIN · APO-ATORVASTATIN · ATORVASTATIN · +35 more21687Yes
RosuvastatinACH-ROSUVASTATIN · ACT ROSUVASTATIN · AG-ROSUVASTATIN · AG-ROSUVASTATIN CALCIUM · +30 more15284Yes
SimvastatinACT SIMVASTATIN · AG-SIMVASTATIN · APO-SIMVASTATIN · AURO-SIMVASTATIN · +34 more21860Yes
PravastatinACH-PRAVASTATIN · ACT PRAVASTATIN · AG-PRAVASTATIN · APO-PRAVASTATIN · +30 more12651Yes
LovastatinACT LOVASTATIN · AVA-LOVASTATIN · DOM-LOVASTATIN · LOVASTATIN · +13 more352Yes
FluvastatinLESCOL 20MG · LESCOL 40MG · LESCOL XL · SANDOZ FLUVASTATIN · +2 more82Yes
CerivastatinBAYCOL · BAYCOL (0.2MG) · BAYCOL (0.3MG)40Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC C10A

ATC subgroupMoleculesDINsMarketed
C10AXAlirocumab · Dextrothyroxine · Evinacumab · Evolocumab · Ezetimibe · +5 more4828
C10ABBezafibrate · Clofibrate · Fenofibrate · Gemfibrozil8713
C10ACColesevelam · Colestipol · Colestyramine296
C10ADNicotinic Acid60

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is AG-PRAVASTATIN called?

The same molecule, Pravastatin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
APX-PravastatinLatinAustralia
PravacholLatinAustralia
Pravastatin SandozLatinAustralia, Sweden
PRAVASTATIN-WGRLatinAustralia
ColiteLatinSouth Africa
Arrow PravastatinLatinSouth Africa
Aspen PravastatinLatinSouth Africa
PravaLatinSouth Africa
Pravastatin TevaLatinSweden
PranalipLatinSouth Africa

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for AG-PRAVASTATIN

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database and the approved product monograph (PDF). Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02476150. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.